In the suspension of production of the coronavirus vaccine, at The only factory that currently has production lines for this work, proceeded at the end of 2021, without … drumbeats, the American pharmaceutical company Johnson & Johnson as revealed by the New York Times.
The American newspaper, citing people who know the decision, reports that the cessation of production of the vaccines by the company is temporary, as the factory in Leiden, the Netherlands is expected to start producing the vaccine again after a few months.
However, according to NYT, the facility in the Dutch city is instead preparing an experimental but potentially more profitable vaccine for another virus. It is unknown at this time what he will do after leaving the post.
In the coming months, however, according to one person familiar with the decision, the suspension is likely to reduce the supply of Johnson & Johnson’s product for Covid-19 by several hundred million doses, while other vaccine production facilities have not yet been put into operation, or have not been approved by the vaccine regulatory authorities.
Johnson & Johnson’s move reportedly exposed it to the eyes of two of its most important clients: the African Union and the Covax Agency, which is responsible for distributing vaccines to poor countries. In fact, the leaders of these organizations learned about the cessation of production by New York Times journalists.
“It’s not the time to change lines “Production for anything, when the lives of people around the developing world are hanging in the balance,” he said. Ayoade Alakija, co-chair of the African Union Vaccine Delivery Program.
Jake Sargent, a spokesman for Johnson & Johnson, said in an email that the company “is focused on making sure our vaccine is available where people are in need” and that “its global production network is working day and night to help in the fight against the pandemic “.
Last summer, Johnson & Johnson had predicted it would deliver one billion doses of its Covid vaccine by 2021. The company produced just 400 million doses, according to a person familiar with the company’s vaccine production.
See all the news
nytimes.com
Follow Skai.gr on Google News
and be the first to know all the news
